Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Hansen

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Canadian Journal of Surgery. Journal Canadien De Chirurgie|February 25, 2017
The adequacy of hepatopancreatobiliary training: How does operative exposure and perceived readiness in fellowship translate into subsequent practice?Jean-Michel Aubin, Alexsander K Bressan, Janet P Edwards, et al.
Journal for Immunotherapy of Cancer|December 2, 2014
Detailed characterization of tumor infiltrating lymphocytes in two distinct human solid malignancies show phenotypic similaritiesMagdalena Kovacsovics-Bankowski, Lana Chisholm, Jonna Vercellini, et al.
Annals of Surgical Oncology|June 3, 2022
Drug-Eluting Bead, Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarcinoma (DELTIC) with Concomitant Systemic Gemcitabine and CisplatinRobert C G Martin, Kerri A Simo, Paul Hansen, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 14, 2017
Training in Minimally Invasive Pancreatic Resections: a paradigm shift away from "See one, Do one, Teach one"Melissa E Hogg, Marc G Besselink, Pierre-Alain Clavien, et al.
Plos One|September 1, 2020
Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancerBrady Bernard, Venkatesh Rajamanickam, Christopher Dubay, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 22, 2020
Pancreatic grade 3 neuroendocrine tumors behave similarly to neuroendocrine carcinomas following resection: a multi-center, international appraisal of the WHO 2010 and WHO 2017 staging schema for pancreatic neuroendocrine lesionsPatrick J Worth, Julie Leal, Qian Ding, et al.
Oncoimmunology|April 2, 2021
Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancerAndrew J Gunderson, Venkatesh Rajamanickam, Cynthia Bui, et al.
Surgery|May 16, 2022
Clinical features and postoperative survival in patients with sporadic versus multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: An international cohort studyJohn R Bergquist, Omair A Shariq, Amy Y Li, et al.
The Lancet. Infectious Diseases|April 17, 2025
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistanceHatim Sati, Elena Carrara, Alessia Savoldi, et al.
The Lancet. Infectious Diseases|December 26, 2017
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosisEvelina Tacconelli, Elena Carrara, Alessia Savoldi, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Canadian Journal of Surgery. Journal Canadien De Chirurgie|February 25, 2017
The adequacy of hepatopancreatobiliary training: How does operative exposure and perceived readiness in fellowship translate into subsequent practice?Jean-Michel Aubin, Alexsander K Bressan, Janet P Edwards, et al.
Journal for Immunotherapy of Cancer|December 2, 2014
Detailed characterization of tumor infiltrating lymphocytes in two distinct human solid malignancies show phenotypic similaritiesMagdalena Kovacsovics-Bankowski, Lana Chisholm, Jonna Vercellini, et al.
Annals of Surgical Oncology|June 3, 2022
Drug-Eluting Bead, Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarcinoma (DELTIC) with Concomitant Systemic Gemcitabine and CisplatinRobert C G Martin, Kerri A Simo, Paul Hansen, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 14, 2017
Training in Minimally Invasive Pancreatic Resections: a paradigm shift away from "See one, Do one, Teach one"Melissa E Hogg, Marc G Besselink, Pierre-Alain Clavien, et al.
Plos One|September 1, 2020
Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancerBrady Bernard, Venkatesh Rajamanickam, Christopher Dubay, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 22, 2020
Pancreatic grade 3 neuroendocrine tumors behave similarly to neuroendocrine carcinomas following resection: a multi-center, international appraisal of the WHO 2010 and WHO 2017 staging schema for pancreatic neuroendocrine lesionsPatrick J Worth, Julie Leal, Qian Ding, et al.
Oncoimmunology|April 2, 2021
Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancerAndrew J Gunderson, Venkatesh Rajamanickam, Cynthia Bui, et al.
Surgery|May 16, 2022
Clinical features and postoperative survival in patients with sporadic versus multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: An international cohort studyJohn R Bergquist, Omair A Shariq, Amy Y Li, et al.
The Lancet. Infectious Diseases|April 17, 2025
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistanceHatim Sati, Elena Carrara, Alessia Savoldi, et al.
The Lancet. Infectious Diseases|December 26, 2017
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosisEvelina Tacconelli, Elena Carrara, Alessia Savoldi, et al.
Pageof 9